558 related articles for article (PubMed ID: 16014920)
21. Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif.
Xiao Z; Ehrlich E; Yu Y; Luo K; Wang T; Tian C; Yu XF
Virology; 2006 Jun; 349(2):290-9. PubMed ID: 16530799
[TBL] [Abstract][Full Text] [Related]
22. Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif.
Russell RA; Smith J; Barr R; Bhattacharyya D; Pathak VK
J Virol; 2009 Feb; 83(4):1992-2003. PubMed ID: 19036809
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a novel Cullin5 binding domain in HIV-1 Vif.
Xiao Z; Xiong Y; Zhang W; Tan L; Ehrlich E; Guo D; Yu XF
J Mol Biol; 2007 Oct; 373(3):541-50. PubMed ID: 17869271
[TBL] [Abstract][Full Text] [Related]
24. Dispersed sites of HIV Vif-dependent polyubiquitination in the DNA deaminase APOBEC3F.
Albin JS; Anderson JS; Johnson JR; Harjes E; Matsuo H; Krogan NJ; Harris RS
J Mol Biol; 2013 Apr; 425(7):1172-82. PubMed ID: 23318957
[TBL] [Abstract][Full Text] [Related]
25. Vif Proteins from Diverse Human Immunodeficiency Virus/Simian Immunodeficiency Virus Lineages Have Distinct Binding Sites in A3C.
Zhang Z; Gu Q; Jaguva Vasudevan AA; Jeyaraj M; Schmidt S; Zielonka J; Perković M; Heckel JO; Cichutek K; Häussinger D; Smits SHJ; Münk C
J Virol; 2016 Nov; 90(22):10193-10208. PubMed ID: 27581978
[TBL] [Abstract][Full Text] [Related]
26. Identification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteins.
Wang J; Zhang W; Lv M; Zuo T; Kong W; Yu X
J Virol; 2011 Dec; 85(23):12482-91. PubMed ID: 21957297
[TBL] [Abstract][Full Text] [Related]
27. Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential for Vif function.
Kobayashi M; Takaori-Kondo A; Miyauchi Y; Iwai K; Uchiyama T
J Biol Chem; 2005 May; 280(19):18573-8. PubMed ID: 15781449
[TBL] [Abstract][Full Text] [Related]
28. The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex.
Bergeron JR; Huthoff H; Veselkov DA; Beavil RL; Simpson PJ; Matthews SJ; Malim MH; Sanderson MR
PLoS Pathog; 2010 Jun; 6(6):e1000925. PubMed ID: 20532212
[TBL] [Abstract][Full Text] [Related]
29. Both Rbx1 and Rbx2 exhibit a functional role in the HIV-1 Vif-Cullin5 E3 ligase complex in vitro.
Wang X; Wang X; Wang W; Zhang J; Wang J; Wang C; Lv M; Zuo T; Liu D; Zhang H; Wu J; Yu B; Kong W; Wu H; Yu X
Biochem Biophys Res Commun; 2015 Jun; 461(4):624-9. PubMed ID: 25912140
[TBL] [Abstract][Full Text] [Related]
30. APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.
Han Y; Wang X; Dang Y; Zheng YH
PLoS Pathog; 2008 Jul; 4(7):e1000095. PubMed ID: 18604271
[TBL] [Abstract][Full Text] [Related]
31. Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function.
Albin JS; Haché G; Hultquist JF; Brown WL; Harris RS
J Virol; 2010 Oct; 84(19):10209-19. PubMed ID: 20686027
[TBL] [Abstract][Full Text] [Related]
32. HIV-1 Vif N-terminal motif is required for recruitment of Cul5 to suppress APOBEC3.
Evans SL; Schön A; Gao Q; Han X; Zhou X; Freire E; Yu XF
Retrovirology; 2014 Jan; 11():4. PubMed ID: 24422669
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Vif-Mediated Degradation of APOBEC3G through Competitive Binding of Core-Binding Factor Beta.
Miyagi E; Welbourn S; Sukegawa S; Fabryova H; Kao S; Strebel K
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941780
[TBL] [Abstract][Full Text] [Related]
34. Identification of a Conserved Interface of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Vifs with Cullin 5.
Gu Q; Zhang Z; Gertzen CGW; Häussinger D; Gohlke H; Münk C
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263270
[TBL] [Abstract][Full Text] [Related]
35. A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity.
Zhen A; Wang T; Zhao K; Xiong Y; Yu XF
J Virol; 2010 Feb; 84(4):1902-11. PubMed ID: 19939923
[TBL] [Abstract][Full Text] [Related]
36. Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection.
Jäger S; Kim DY; Hultquist JF; Shindo K; LaRue RS; Kwon E; Li M; Anderson BD; Yen L; Stanley D; Mahon C; Kane J; Franks-Skiba K; Cimermancic P; Burlingame A; Sali A; Craik CS; Harris RS; Gross JD; Krogan NJ
Nature; 2011 Dec; 481(7381):371-5. PubMed ID: 22190037
[TBL] [Abstract][Full Text] [Related]
37. A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G.
Chen G; He Z; Wang T; Xu R; Yu XF
J Virol; 2009 Sep; 83(17):8674-82. PubMed ID: 19535450
[TBL] [Abstract][Full Text] [Related]
38. Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex.
Shirakawa K; Takaori-Kondo A; Kobayashi M; Tomonaga M; Izumi T; Fukunaga K; Sasada A; Abudu A; Miyauchi Y; Akari H; Iwai K; Uchiyama T
Virology; 2006 Jan; 344(2):263-6. PubMed ID: 16303161
[TBL] [Abstract][Full Text] [Related]
39. Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines.
Yu Y; Xiao Z; Ehrlich ES; Yu X; Yu XF
Genes Dev; 2004 Dec; 18(23):2867-72. PubMed ID: 15574593
[TBL] [Abstract][Full Text] [Related]
40. Zinc chelation inhibits HIV Vif activity and liberates antiviral function of the cytidine deaminase APOBEC3G.
Xiao Z; Ehrlich E; Luo K; Xiong Y; Yu XF
FASEB J; 2007 Jan; 21(1):217-22. PubMed ID: 17135358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
